Atara Biotherapeutics, Inc.
Atara develops off-the-shelf allogeneic T-cell therapies for cancers and autoimmune conditions.
10-QNov 10Latest SEC filing
Nov 10Latest story
November 2026
August 2026
Atara develops off-the-shelf allogeneic T-cell therapies for cancers and autoimmune conditions.